Publications & Presentations Our innovative development programs are backed by sound scientific research. Filter by All Publications Data Presentations Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia in Patients with Congenital Hyperinsulinism Davelyn Eaves Hood MD et al. ESPE 2021 Single Dose Studies of RZ358 in Patients with Congenital Hyperinsulinism: Results of Population PK/PD Modeling and Simulation in Adult and Pediatric Patients Daniel Epling et al. Pediatric Endocrine Society (PES) 05/30/20 RZ358-606 RIZE Study: An Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism Nevan Charles Elam et al. Data Call 05/01/20 Targeting rare and metabolic diseases with transformative therapies Company Internal Biopharma Dealmakers 11/2019 Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers Kirk W. Johnson et al. The Journal of Clinical Endocrinology & Metabolism 08/2017 XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial Rajneesh Nath et al. ENDO 2015 Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: A potential new approach for the treatment of hyperinsulinemic hypoglycemia John A Corbin et al. mAbs 01/2014 12
